Answers are grounded in this paper and cite their sources.
BACKGROUND: This study evaluates clinical and economic outcomes among patients who received cementless, medial collared, triple-tapered hip stem (TTS) compared to other hip systems (non-TTS) for solely the posterior approach in THA. METHODS: This retrospective cohort study used US Medicare SAF data for THA patients from 1 January 2016 to 31 December 2023. Researchers compared outcomes from 11 surgeons performing posterior approach THA, selected based on expertise and identified via National Provider Identifier (NPI). The primary outcome was 3-month reoperation rate; exploratory outcomes included 2-year healthcare resource utilization and complication rates. Cohorts were balanced with propensity score fine stratification and analyzed using generalized linear models. RESULTS: There were 1,042 TTS and 1,483 non-TTS patients. The reoperation rate at 3 months was 2.3% for TTS and 2.8% for non-TTS. The 24-month dislocation rate was 2.3% for TTS and 4.6% for non-TTS, while the peri-prosthetic fracture rate was 2.1% for TTS and 1.1% for non-TTS. Twenty-four-month Medicare payments were similar for TTS ($29,310) and non-TTS ($28,542). CONCLUSIONS: The reoperation rate was found to be non-inferior for the TTS compared to the non-TTS cohort for posterior THA. The results demonstrate that TTS is an effective option for the posterior approach in THA.
No takes yet. Share an insight, caveat, or question.
Germano et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: